Notice of Closed Meeting, 77615 [2022-27454]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 242 / Monday, December 19, 2022 / Notices
with the FAR provision 52.225–18,
Place of Manufacture. This provision
requires offerors of manufactured end
products to indicate in response to a
solicitation, by checking a box, whether
the place of manufacture of the end
products it expects to provide is
predominantly manufactured in the
United States or outside the United
States. Contracting officers use the
information as the basis for entry into
the Federal Procurement Data System
for further data on the rationale for
purchasing foreign manufactured items.
The data is necessary for analysis of the
application of the Buy American statute
and the trade agreements.
C. Annual Burden
Respondents: 50,106.
Total Annual Responses: 2,600,361.
Total Burden Hours: 26,004.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the GSA
Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 9000–0161, Reporting
Purchases from Sources Outside the
United States, in all correspondence.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–27430 Filed 12–16–22; 8:45 am]
[FR Doc. 2022–27454 Filed 12–16–22; 8:45 am]
BILLING CODE 6820–EP–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Centers for Disease Control and
Prevention
[CMS–3429–FN]
Notice of Closed Meeting
tkelley on DSK125TN23PROD with NOTICE
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–OH–22–002, NIOSH Centers for
Agricultural Safety and Health.
Date: March 7, 2023.
Time: 11:00 a.m.–6:00 p.m., EST.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Officer, Office of
Extramural Programs, National Institute
for Occupational Safety and Health,
CDC, 1095 Willowdale Road,
Morgantown, West Virginia, 26505;
Telephone: (304) 285–5879; Email:
MRidenour@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
VerDate Sep<11>2014
19:38 Dec 16, 2022
Jkt 259001
Medicare and Medicaid Programs:
Application From the Center for
Improvement in Healthcare Quality for
Continued Approval of Its Hospital
Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces our
decision to approve the Center for
Improvement in Healthcare Quality
(CIHQ) for continued recognition as a
national accrediting organization for
hospitals that wish to participate in the
Medicare or Medicaid programs.
DATES: The decision announced in this
notice is applicable January 1, 2023
through January 1, 2028.
FOR FURTHER INFORMATION CONTACT:
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
77615
Erin Imhoff, (410) 786–2337.
Caecilia Blondiaux, (410) 786–2190.
SUPPLEMENTARY INFORMATION:
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from a hospital, provided
certain requirements are met. Section
1861(e) of the Social Security Act (the
Act) establishes statutory authority for
the Secretary of the Department of
Health and Human Services (Secretary)
to set distinct criteria for facilities
seeking designation as a hospital.
Regulations concerning provider
agreements are at 42 CFR part 489 and
those pertaining to activities relating to
the survey and certification of facilities
are at 42 CFR part 488. The regulations
at 42 CFR part 482 specify the minimum
conditions of participation that a
hospital must meet to participate in the
Medicare program.
Generally, to enter into an agreement,
a hospital must first be certified by a
state survey agency (SA) as complying
with the conditions or requirements set
forth in part 482 of our regulations.
Thereafter, the hospital is subject to
regular surveys by a SA to determine
whether it continues to meet these
requirements.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by a Centers for
Medicare & Medicaid Services (CMS)
approved national accrediting
organization (AO) that all applicable
Medicare requirements are met or
exceeded, we will deem those provider
entities as having met such
requirements. Accreditation by an AO is
voluntary and is not required for
Medicare participation.
If an AO is recognized by the
Secretary of the Department of Health
and Human Services (the Secretary) as
having standards for accreditation that
meet or exceed Medicare requirements,
any provider entity accredited by the
national accrediting body’s approved
program would be deemed to meet the
Medicare requirements. A national AO
applying for approval of its
accreditation program under part 488,
subpart A, must provide CMS with
reasonable assurance that the AO
requires the accredited provider entities
to meet requirements that are at least as
stringent as the Medicare requirements.
Our regulations concerning the approval
of AOs are set forth at §§ 488.4, 488.5
and 488.5(e)(2)(i). The regulations at
§ 488.5(e)(2)(i) require AOs to reapply
for continued approval of its
accreditation program every 6 years or
sooner, as determined by CMS.
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 87, Number 242 (Monday, December 19, 2022)]
[Notices]
[Page 77615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27454]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--RFA-OH-22-002, NIOSH Centers for
Agricultural Safety and Health.
Date: March 7, 2023.
Time: 11:00 a.m.-6:00 p.m., EST.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Officer, Office of Extramural Programs, National
Institute for Occupational Safety and Health, CDC, 1095 Willowdale
Road, Morgantown, West Virginia, 26505; Telephone: (304) 285-5879;
Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-27454 Filed 12-16-22; 8:45 am]
BILLING CODE 4163-18-P
